Quarterly report pursuant to sections 13 or 15(d)

Condensed Consolidated Statements of Operations

v2.4.0.8
Condensed Consolidated Statements of Operations (USD $)
In Thousands, except Share data, unless otherwise specified
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Revenue $ 4,952 $ 6,311
Cost of sales 3,294 3,650
Gross profit 1,658 2,661
Selling, general and administrative:    
Severance and transition costs 81 805
Acquisition related expenses 364 1,055
Amortization and depreciation 554 988
Stock based compensation 132 192
Other selling, general and administrative 3,435 2,053
Research and development 504 459
Total operating expenses 5,070 5,552
Operating loss (3,412) (2,891)
Non-operating income (expense):    
Change in fair value of embedded derivative   (3,169)
Gain on bargain purchase of business   742
Interest expense (87)  
Other expense (8)  
Total non-operating income (expense), net (95) (2,427)
Net loss (3,507) (5,318)
Accrual of preferred stock dividends (400) (277)
Accretion to redemption value of Series E and F preferred stock (7) (2,171)
Net loss attributable to common stockholders $ (3,914) $ (7,766)
Basic and diluted loss per common share attributable to common stockholders $ (0.05) $ (0.11)
Basic and diluted weighted average shares outstanding 81,365 71,659